| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.00095 | 1 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.00097 | 1 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.0009 | 1 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.00064 | 1 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.00091 | 1 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.00048 | 1 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00042 | 1 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.00039 | 1 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.00041 | 1 |